Oxford Asset Management’s Insmed INSM Stock Holding History

Oxford Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,931	Closed	-$684K	–	608
2025 Q4	$684K	Sell	3,931 -4,377	-53%	-$799K	0.25%	131
2025 Q3	$1.2M	Buy	8,308 +3,811	+85%	+$467K	0.4%	57
2025 Q2	$453K	Buy	+4,497	New	+$344K	0.15%	223
2017 Q4	–	Sell	-57,537	Closed	-$1.78M	–	1735
2017 Q3	$1.78M	Buy	+57,537	New	+$1.1M	0.03%	673
2015 Q4	–	Sell	-44,427	Closed	-$825K	–	909
2015 Q3	$825K	Sell	44,427 -16,506	-27%	-$412K	0.03%	433
2015 Q2	$1.49M	Sell	60,933 -147,872	-71%	-$3.36M	0.04%	386
2015 Q1	$4.34M	Buy	+208,805	New	+$3.68M	0.11%	214
2014 Q3	–	Sell	-377,173	Closed	-$7.53M	–	705
2014 Q2	$7.53M	Buy	377,173 +64,776	+21%	+$959K	0.24%	111
2014 Q1	$5.95M	Buy	+312,397	New	+$5.94M	0.17%	191
2013 Q3	–	Sell	-14,962	Closed	-$179K	–	847
2013 Q2	$179K	Buy	+14,962	New	+$153K	﹤0.01%	801

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oxford Asset Management's INSM Position: Q1 2026 in Review

Oxford Asset Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 3,931 shares — an estimated $684K sold.

Oxford Asset Management first reported a position in INSM in Q2 2013 and held it in 10 quarters. The position peaked at $7.53M in Q2 2014. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Oxford Asset Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Oxford Asset Management sold 3,931 Insmed shares in Q1 2026, an estimated $684K.
Oxford Asset Management first reported a position in Insmed in Q2 2013 and held it in 10 quarters.
Oxford Asset Management's Insmed position peaked at $7.53M in Q2 2014.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.